Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
1. BlackRock

Portfolio > ETFs

BlackRock Launches iShares Neuroscience and Health Care ETF

Your article was successfully shared with the contacts you provided.

BlackRock launched a new thematic ETF on the New York Stock Exchange on Friday, the iShares Neuroscience and Healthcare ETF (IBRN), which the firm said is the first ETF focused on neuroscience and the growth and innovation related to the treatment of neurological diseases.

The fund, with a 0.47% expense ratio, seeks to track the investment results of an index designed to measure U.S. and non-U.S. companies in the neuroscience sphere. Its benchmark is the NYSE FactSet Global Neuro Biopharma and MedTech Index.

“Neurological and mental health diseases are among the most prevalent and destructive health conditions in the world, but innovations in neuroscience are leading to an acceleration of medical breakthroughs and treatments,”  Jeff Spiegel, head of iShares megatrend, international and sector ETFs at BlackRock, said in a statement.

“Through IBRN, investors can gain exposure to those companies leading these advancements across the theme’s entire value chain,” Spiegel added.

IBRN is part of BlackRock’s megatrend ETF lineup, and its launch follows expansion of that platform last week with the BlackRock Future Financial and Technology ETF.

(Image: Bloomberg) 


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.